Impact of obesity on left ventricular systolic function in hypertensive subjects with normal ejection fraction

Insights

Obesity may impair cardiac contractility in hypertensive individuals. This study found that increased body mass index (BMI) independently reduces left ventricular (LV) myocardial contractility, even with normal ejection fraction (EF).

Area of Science:

  • Cardiology
  • Obesity Medicine
  • Cardiovascular Physiology

Background:

  • Hypertension and obesity are prevalent risk factors for cardiovascular disease.
  • Left ventricular (LV) systolic function is crucial for maintaining cardiac output.
  • The impact of obesity on LV systolic function, particularly in hypertensive patients with preserved ejection fraction (EF), requires further elucidation.

Discussion:

  • Obesity, indicated by body mass index (BMI), was independently associated with reduced myocardial contractility.
  • While longitudinal systolic function (assessed by atrio-ventricular plane displacement and mitral annular systolic velocity) remained unaffected, circumferential contractility was significantly depressed in obese individuals.
  • The findings suggest an additive interaction between obesity and hypertension on cardiac function, rather than a synergistic effect.

Key Insights:

  • Circumferential myocardial contractility is significantly impaired in obese hypertensive patients with normal EF.
  • Increased BMI is an independent predictor of reduced LV myocardial contractility.
  • Obesity exacerbates cardiac dysfunction in hypertension, impacting contractility independent of EF.

Outlook:

  • Further research should explore the specific mechanisms linking obesity to impaired circumferential contractility.
  • Longitudinal studies are needed to determine if this reduction in contractility precedes or follows the development of other cardiovascular complications.
  • Therapeutic strategies targeting weight management may be crucial for preserving cardiac function in hypertensive populations.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...